Synthetic antigen evoking anti-hiv responese
CA 1340907 C · Owner: Moss, Bernard · Inventors: Takahashi, Hidemi; Hosmalin, Anne; Berzofsky, Jay A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A synthetic oligopeptide which evokes anti-HIV response has been prepared. The oligopeptide is useful as a vaccine and as a diagnostic, prognostic and therapeutic agent in cases of HIV infection. The peptide is selected from the group of peptides consisting of the Env-K1 peptide and peptides that are functionally equivalent variants of the Env-K1 peptide. The variants can be derived from the Env-K1 peptide by addition, deletion, substitution or derivatization of at least one amino acid thereof.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted February 22, 2000. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended February 22, 2017.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.